Caribou Biosciences, Inc.

Direct answer

Caribou Biosciences, Inc. is publicly traded on NASDAQ under the ticker CRBU.

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally. Among its primary therapeutic candidates are CB-010, an allogeneic anti-CD19 CAR-T cell...

Can you invest in Caribou Biosciences, Inc.?

Yes. Caribou Biosciences, Inc. trades publicly on NASDAQ as CRBU.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Caribou Biosciences, Inc.

Detailed equity research is provided by MarketSnap.